Characteristics | All participants (n = 716) | Gout (n = 653) | Asymptomatic hyperuricemia (n = 63) |
---|---|---|---|
Male, n (%) | 604 (84.4) | 553 (84.7) | 51 (81.0) |
Age (years) | 47.8 ± 16.0 | 48.3 ± 15.8 | 43.2 ± 17.9 |
Education level | |||
Primary education or below | 85 (11.9) | 75 (11.5) | 10 (15.9) |
University or above | 376 (52.5) | 350 (53.6) | 26 (41.3) |
Weight (kg) | 67.5 (15.0) | 63.0 (15.0) | 67.0 ± 11.3 |
BMI (kg/ m2) | 24.2 (5.06) | 23.4 (4.7) | 24.1 ± 3.2 |
Normal (18.5~24.9), n(%) | 350 (48.9) | 319 (48.9) | 31 (49.2) |
Overweight (25.0~29.9), n(%) | 217 (30.3) | 199 (30.5) | 18 (28.6) |
Obesity (30.0~34.9), n(%) | 38 (5.3) | 37 (5.7) | 1 (1.6) |
Severe obesity (35.0~39.9), n(%) | 6 (0.8) | 6 (0.9) | 0 |
Smoking (current), n (%) | 171 (23.9) | 153 (23.4) | 18 (28.5) |
Drinking (current), n (%) | 348 (48.6) | 322 (49.3) | 26 (41.3) |
Duration of hyperuricemia (years) | 6.0 (2.0–12.0) | 6.0 (2.0–12.0) | 6.0 (2.0–11.0) |
Treatment, n (%) | |||
UA lowering therapy | 430 (60.0) | 423 (64.8) | 7 (11.1) |
No medication | 248 (34.6) | 198 (30.3) | 50 (79.4) |